May 2016

ALS Association opens in Modesto

The Amyotrophic Lateral Sclerosis (ALS) Association has opened a Modesto office ... Although the value of stem cell research has drawn criticism as being mostly smoke and mirrors, the ALS Association has recently put out a piece saying it shares a sense ...

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

Conditions:   Acute Lymphoblastic Leukemia (ALL);   Acute Myeloid Leukemia (AML);   Myeloid Sarcoma;   Chronic Myeloid Leukemia (CML);   Juvenile Myelomonocytic Leukemia (JMML);   Myelodysplastic Syndrome (MDS);   Non-Hodgkin Lymphoma (NHL)
Interventions:   Drug: Anti-thymocyte globulin (rabbit);   Drug: Blinatumomab;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: G-CSF;   Drug: Melphalan;   Drug: Mesna;   Drug: Rituximab;   Drug: Tacrolimus;   Drug: Thiotepa;   Biological: HPC,A Infusion
Sponsor:   St. Jude Children's Research Hospital

Monongah students hop for a good cause

The MDA funds research, offers care and offers support and services to individuals who have muscular dystrophy, amyotrophic lateral sclerosis and other related muscle-debilitating diseases, according to Spinal muscular atrophy is one of the dise ...

Environmental toxins — modifiable risk factors for ALS?

Environmental pollutants, such as pesticides and flame retardants, are associated with an increased risk of amyotrophic lateral sclerosis (ALS) and could represent modifiable risk factors for this condition, according to new research by Eva Feldman ...

Annual Islip Family Run for ALS research slated for May 21

Amyotrophic lateral sclerosis (ALS) strikes people between the ages of 40 and 70, and approximately 20,000 Americans can have the disease at any given time, according to the ALS Association. It is also referred to as Lou Gehrig’s disease because the ...

Mexiletine in Sporadic Amyotrophic Lateral Sclerosis

Condition:   Sporadic Amyotrophic Lateral Sclerosis
Interventions:   Drug: Mexiletine;   Drug: Placebo
Sponsors:   University of Washington;   Massachusetts General Hospital
Recruiting - verified December 2016